Considering the fact that an elevated PXR expression has also been observed in various pancreatic cells [26], treatment of pancreatic cancer with a combination therapy approach is more likely to be successful with nemorosone rather than hyperforin. This evidence concerns the gene NR1I2 and familial pancreatic carcinoma.